Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study
2009 StandoutNobel
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
Tension-Free Inguinal Hernia Repair: The Design of a Trial to Compare Open and Laparoscopic Surgical Techniques
2003
Chronic Myeloproliferative Disorders
2003
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors
1990
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected*
2002
EFFECTS OF HYPOXEMIA ON EARLY POSTOPERATIVE COURSE OF LIVER TRANSPLANTATION IN PEDIATRIC PATIENTS WITH INTRAPULMONARY SHUNTING1
1997
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis
2015
Transjugular kidney biopsy
2004
Vascular disorders of the liver # †
2008 Standout
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management
2012
Open Mesh versus Laparoscopic Mesh Repair of Inguinal Hernia
2004 Standout
Nanorobotic Applications in Medicine: Current Proposals and Designs
2014
Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors
2000
The Ratio of Blood Products Transfused Affects Mortality in Patients Receiving Massive Transfusions at a Combat Support Hospital
2007 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence‐based review
2005 Standout
Bone Marrow Histopathology in Myeloproliferative Disorders—Current Diagnostic Approach
2005
Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis
2005
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis
1999
Pulmonary Hypertension Associated with Myeloproliferative Disorders: A Retrospective Study of Ten Cases
2007
Platelet Density Distribution in Essential Thrombocythemia
2010 StandoutNobel
2 The histopathology of chronic myeloproliferative diseases
1998
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia
1999
Coagulation defects in trauma patients: etiology, recognition, and therapy
2004
Expertise-Based Management in Essential Thrombocythemia and Polycythemia Vera
2007
More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate
2015 StandoutNobel
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Measuring antiplatelet drug effects in the laboratory
2007
How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults
2007
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Reversal of Dabigatran-induced Bleeding by Coagulation Factor Concentrates in a Rat-tail Bleeding Model and Lack of Effect on Assays of Coagulation
2014
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Biliary complications in pediatric living related liver transplantation
1998 StandoutNobel
Multidisciplinary management of a Jehovah’s Witness patient for the removal of a renal cell carcinoma extending into the right atrium
2002
Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disorders
1989
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Primary Myelofibrosis: Update on Definition, Pathogenesis, and Treatment
2008
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.
2016
International consensus statement on the peri‐operative management of anaemia and iron deficiency
2016 Standout
Masked polycythemia Vera (mPV): Results of an international study
2013
Polycythemia vera: myths, mechanisms, and management
2002
Myeloproliferative disorders
2008
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies
2011
Hepatic and portal vein thrombosis in cirrhosis: Possible role in development of parenchymal extinction and portal hypertension
1995
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
1999 Standout
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of Powers Peterson being referenced
Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: A clinicopathological study of 145 patients examined at autopsy†
1990
Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding
1996
Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome
1988
The Preoperative Bleeding Time Test Lacks Clinical Benefit
1998
Treatment of anemia in myeloproliferative disorders: a randomized study of fluoxymesterone v transfusions only.
1982
The bone marrow in polycythemia vera.
1979
Myelofibrosis in the myeloproliferative disorders.
1984
Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
1986
From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
1997
The Preoperative Bleeding Time Test Lacks Clinical Benefit. College of American Pathologists' and American Society of Clinical Pathologists' Position Article
1998